ARCHIVES

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

This article is from The Cancer Letter archive.

Vol. 23 No. 48 | December 19, 1997

Download PDF Visit The Full Archive

Related Articles

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010